A medication-driven magnesium deficiency score is associated with increased depressive symptoms prevalence independent of renal function: Evidence from NHANES 1999–2018
Journal of Affective Disorders · 2025-12 · 390 · 119801
DOI: 10.1016/j.jad.2025.119801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025-12. Verfasst von Jian Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Capital Medical University China-Japan Friendship School of Clinical Medicine, No. 2 East Yinghuayuan Street, Chaoyang Dist…. Hauptthemen laut MEDLINE: Magnesium Deficiency, Depression, Diuretics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Magnesium deficit is considered to be a risk factor for depression. This study aimed to determine the relationship between Magnesium Depletion Score (MgDS) and depressive symptoms. METHODS: A total of 20,893 participants were included from the National Health and Nutrition Examination Survey (NHANES) conducted between 1999 and 2018. Depressive symptoms was defined using a 9-item Patient Health Questionnaire (PHQ-9) (categorized as ≥5 [mild], ≥10 [clinical], and ≥ 15 [moderate-to-severe]). Weighted linear regression examined MgDS association with continuous PHQ-9 scores (range 0-27), while weighted logistic regression analyzed categorical depressive symptoms. Restricted cubic splines (RCS) assessed nonlinear relationships in both models. Sensitivity analyses included severity-stratified and subgroup analyses. RESULTS: For each one-point increase in MgDS, the PHQ-9 score increased by 0.23 points (95 % CI: 0.13-0.32) in the continuous analysis. Similarly, the odds of clinical depressive symptom were increased by 12 % (OR = 1.12, 95 % CI: 1.04-1.21). Use of diuretics and PPIs was independently associated with increased likelihood of having depressive symptoms (OR = 1.24, 95 % CI: 1.04-1.46; OR = 1.95, 95 % CI: 1.64-2.32). In sensitivity analyses, per-unit MgDS increases corresponded to 11 % (mild; OR = 1.11, 1.04-1.17) and 17 % (moderate-to-severe; OR = 1.17, 1.05-1.31) higher odds of depressive symptoms. RCS analysis showed that there was a linear dose-response relationship across the MgDS. The association remained significant in stratified analyses by age, sex, magnesium intake, and comorbidity status. CONCLUSION: MgDS was independently associated with depressive symptoms in a dose-response manner. The use of diuretics and PPIs may contribute to this association through magnesium imbalance, necessitating mechanistic studies and clinical monitoring in high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Capital Medical University China-Japan Friendship School of Clinical Medicine, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, China; Department of Nephrology, China-Japan Friendship…
- Department of Nephrology, Capital Medical University China-Japan Friendship School of Clinical Medicine, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, China.
- Department of Nephrology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, China.
- Department of Nephrology, Peking University China-Japan Friendship School of Clinical Medicine, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, China.
- Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, China.
- Capital Medical University, No. 10 Xitou Tiao, You'anmenwai, Fengtai District, Beijing, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Lu, J., Deng, Z., Cui, W., Shang, X., Jiang, S., Wang, S., & Li, W. (2025). A medication-driven magnesium deficiency score is associated with increased depressive symptoms prevalence independent of renal function: Evidence from NHANES 1999–2018. Journal of Affective Disorders, 390, 119801. https://doi.org/10.1016/j.jad.2025.119801
Vancouver
Lu J, Deng Z, Cui W, Shang X, Jiang S, Wang S, et al. A medication-driven magnesium deficiency score is associated with increased depressive symptoms prevalence independent of renal function: Evidence from NHANES 1999–2018. Journal of Affective Disorders. 2025;390:119801. doi:10.1016/j.jad.2025.119801
BibTeX
@article{Lu2025,
author = {Lu, Jian and Deng, Zekai and Cui, Wen and Shang, Xinru and Jiang, Shimin and Wang, Shunwei and Li, Wenge},
title = {A medication-driven magnesium deficiency score is associated with increased depressive symptoms prevalence independent of renal function: Evidence from NHANES 1999–2018},
journal = {Journal of Affective Disorders},
year = {2025},
volume = {390},
pages = {119801},
doi = {10.1016/j.jad.2025.119801}
}
EUVIMED